CClinicalTrials.gg
WithdrawnNCT06310889EPIC-BSUpdated Mar 18, 2024

Evaluation of Palliative Care Co-treatment by Attending Physicians and Nurses: an Online Survey as Part of the Project

An observational study in Palliative Medicine, sponsored by Charite University, Berlin, Germany. Withdrawn. Open to participants aged 18 Years to 67 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-03-18.

Sponsored by Charite University, Berlin, Germany · Observational

Why this study was withdrawn
Already registered
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
0
Ages
18 Years to 67 Years
Sex
All
01

Study summary

The subject of the study is an online survey of doctors and nurses who provide (intensive) medical care to patients.

Read the detailed description

Charité will support this international survey as part of the preparatory phase of the "Europe-wide harmonized and recommended palliative care practice for ICU" approved HORIZON grant application EPIC (EA2/291/23), to which this ethics application refers.

Participants will be contacted via the mailing list of ESAIC (European Organization for Anaesthesia, Intensive Care, Pain and Perioperative Medicine), ESICM (European Society of Intensive Care Medicine), DIVI (German Interdisciplinary Association for Intensive Care and Emergency Medicine (DIVI) and the European Association for Palliative Care (EAPC).

02

Conditions studied

  • Palliative Medicine
03

In context

Lead sponsor

Charite University, Berlin, Germany is the lead sponsor of 836 studies on the registry; 129 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 67 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Doctors or nursing staff involved in the intensive medical care of patients which can be contacted by a list of a specialist association

Inclusion criteria

  • All doctors or nursing staff involved in the intensive medical care of patients and consent to the survey via the distribution list of a specialist association

Exclusion criteria

Exclusion Criteria:

  • Incomplete data
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
0 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Barriers 1

    Barriers in palliative care regarding implementation of therapeutic goals (implementation rate symptom assessment for e.g. breathing and dyspnea).

    Time frame: 01.04.2024 - 30.06.2024

  2. Barriers 2

    Barriers in palliative care regarding implementation of patient automomy (implementation rate to define advance directives and power of attorney).

    Time frame: 01.04.2024 - 30.06.2024

Secondary outcomes

  1. Measures 1

    Measures to be taken in the palliative medical treatment situation (implementation rate to define and document end-of-life-decisions).

    Time frame: 01.04.2024 - 30.06.2024

  2. Measures 2

    Evaluation of measures to be taken in the palliative medical treatment situation (family involvement in end-of-life-decisions).

    Time frame: 01.04.2024 - 30.06.2024

  3. Resources 1

    Personnel resources in palliative care (rate of specialized palliative care team available in ICUs).

    Time frame: 01.04.2024 - 30.06.2024

  4. Resources 2

    Other resources in palliative care (rate availability of psychological support)

    Time frame: 01.04.2024 - 30.06.2024

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 18, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06310889
Lead sponsor
Charite University, Berlin, Germany
Collaborators
European Commission, National and Kapodistrian University of Athens, King's College Hospital NHS Trust
Responsible party
Claudia Spies (Head of the Department of Anesthesiology and Intensive Care Medicine (CCM/CVK), Charité - Universitätsmedizin Berlin, Charite University, Berlin, Germany) — Principal investigator
First posted
Mar 15, 2024
Start date
Apr 1, 2024 (estimated)
Primary completion
Jun 30, 2024 (estimated)
Completion
Jun 30, 2024 (estimated)
Last update
Mar 18, 2024

Study contacts

Claudia Spies, MD, Prof.
study chair · Charite University, Berlin, Germany

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion